newsfilter
← Latest News
Business Wire·

Biocept Announces Receipt of Deficiency Notice from Nasdaq Regarding Requirement to Timely Quarterly Report on Form 10-Q

Biocept, Inc. (NASDAQ:BIOC), a leading provider of molecular diagnostic assays, products and services, announces that it received a notice (the "Notice") on August 17, 2022 from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasd